Terminated NA INTERVENTIONAL 2-arm NCT00329732

Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks

Double-Blind, Placebo Controlled Trial Of Greater Occipital Nerve Block For The Treatment Of Migraine Status

Sponsor: Thomas Jefferson University

Conditions Migraine

Interventions 0.5% bupivicaine and 2% lidocaine Saline placebo

Updated 7 times since 2017 Last updated: Apr 16, 2015 Started: Mar 31, 2006 Primary completion: Apr 30, 2006 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated due to inadequate recruitment

Other terminated trials from Thomas Jefferson University

See all terminations from Thomas Jefferson University

Other Migraine trials with similar outcome

Browse all Migraine trials

Listed as NCT00329732, this NA trial focuses on Migraine and remains terminated or withdrawn. Sponsored by Thomas Jefferson University, it has been updated 7 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Jan 2021 — Dec 2022 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Thomas Jefferson University

Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States